Delayed granulocyte colony-stimulating factor treatment in rats attenuates mechanical allodynia induced by chronic constriction injury of the sciatic nerve
- PMID: 24253780
- DOI: 10.1097/BRS.0000000000000108
Delayed granulocyte colony-stimulating factor treatment in rats attenuates mechanical allodynia induced by chronic constriction injury of the sciatic nerve
Abstract
Study design: Animal experimental study with intervention.
Objective: The aim of this study was to elucidate therapeutic effects of delayed granulocyte colony-stimulating factor treatment for mechanical allodynia induced by chronic constriction injury (CCI) of the sciatic nerve in rats.
Summary of background data: Granulocyte colony-stimulating factor (G-CSF) is used clinically for patients with hematological disorders. Previous reports showed that immediate G-CSF attenuates neuropathic pain in CCI of the sciatic nerve. However, the acute treatment for neuropathic pain prior to accurate diagnosis is not realistic in clinical settings.
Methods: Adult, female Sprague-Dawley rats were subjected to the CCI model. This model induces mechanical allodynia on the ipsilateral hind paw within the first week after the injury. One week after CCI, rats received intraperitoneal G-CSF (15.0 μg/kg) for 5 consecutive days. Mechanical allodynia was assessed using the von Frey hair test. Immunohistochemistry for phosphorylated p38 mitogen-activated kinase (p-p38MAPK) and OX-42 (a marker for activated microglia) on tissue slides from a subset of rats 2 weeks after surgery. Western blot analyses were carried out to determine protein expression level of p-p38MAPK and interleukin-1 β on spinal cord homogenates 2 weeks after CCI.
Results: Results of the von Frey filament test showed that G-CSF significantly attenuates mechanical allodynia induced by the CCI model. Immunohistochemistry revealed that G-CSF reduced the number of p-p38MAPK-positive cells in the ipsilateral dorsal horn compared with that in the vehicle group rats. Immunofluorescent double staining revealed that p-p38MAPK-expressing cells in the spinal cord dorsal horn are mainly microglia. Western blot analysis indicated that G-CSF decreased the expression levels of both p-p38MAPK and interleukin-1 β in the ipsilateral dorsal horn compared with that in the vehicle group rats.
Conclusion: The present results indicate a beneficial effect of delayed G-CSF treatment in an animal model of peripheral nerve injury-induced neuropathic pain.
Level of evidence: N/A.
Similar articles
-
Granulocyte colony-stimulating factor attenuates spinal cord injury-induced mechanical allodynia in adult rats.J Neurol Sci. 2015 Aug 15;355(1-2):79-83. doi: 10.1016/j.jns.2015.05.024. Epub 2015 May 27. J Neurol Sci. 2015. PMID: 26055312
-
Montelukast attenuates neuropathic pain through inhibiting p38 mitogen-activated protein kinase and nuclear factor-kappa B in a rat model of chronic constriction injury.Anesth Analg. 2014 May;118(5):1090-6. doi: 10.1213/ANE.0000000000000174. Anesth Analg. 2014. PMID: 24686047
-
Activation of extracellular signal-regulated protein kinases 5 in the spinal cord contributes to the neuropathic pain behaviors induced by CCI in rats.Neurol Res. 2009 Dec;31(10):1037-43. doi: 10.1179/174313209X405128. Epub 2009 May 8. Neurol Res. 2009. PMID: 19426589
-
Galanin expression in neuropathic pain: friend or foe?Ann N Y Acad Sci. 1998 Dec 21;863:390-401. doi: 10.1111/j.1749-6632.1998.tb10709.x. Ann N Y Acad Sci. 1998. PMID: 9928185 Review.
-
Granulocyte Colony-Stimulating Factor (G-CSF) for the Treatment of Spinal Cord Injury.CNS Drugs. 2017 Nov;31(11):911-937. doi: 10.1007/s40263-017-0472-6. CNS Drugs. 2017. PMID: 29063471 Review.
Cited by
-
Granulocyte Colony Stimulating Factor (GCSF) Can Attenuate Neuropathic Pain by Suppressing Monocyte Chemoattractant Protein-1 (MCP-1) Expression, through Upregulating the Early MicroRNA-122 Expression in the Dorsal Root Ganglia.Cells. 2020 Jul 11;9(7):1669. doi: 10.3390/cells9071669. Cells. 2020. PMID: 32664488 Free PMC article.
-
Granulocyte colony-stimulating factor promotes regeneration of severed facial nerve in rats.Front Neurosci. 2024 Dec 5;18:1442614. doi: 10.3389/fnins.2024.1442614. eCollection 2024. Front Neurosci. 2024. PMID: 39712221 Free PMC article.
-
An early granulocyte colony-stimulating factor treatment attenuates neuropathic pain through activation of mu opioid receptors on the injured nerve.Sci Rep. 2016 May 16;6:25490. doi: 10.1038/srep25490. Sci Rep. 2016. PMID: 27180600 Free PMC article.
-
Interactions between Autophagy, Proinflammatory Cytokines, and Apoptosis in Neuropathic Pain: Granulocyte Colony Stimulating Factor as a Multipotent Therapy in Rats with Chronic Constriction Injury.Biomedicines. 2021 May 12;9(5):542. doi: 10.3390/biomedicines9050542. Biomedicines. 2021. PMID: 34066206 Free PMC article.
-
MSC encapsulation in alginate microcapsules prolongs survival after intra-articular injection, a longitudinal in vivo cell and bead integrity tracking study.Cell Biol Toxicol. 2020 Dec;36(6):553-570. doi: 10.1007/s10565-020-09532-6. Epub 2020 May 30. Cell Biol Toxicol. 2020. PMID: 32474743 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials